The global pericardium diseases market is expected to grow at a CAGR of 8.2% during the forecast period 2017-2023.
The global pericardium diseases market is majorly driven by the increasing prevalence of pericardium diseases.
Additionally, increasing healthcare expenditure, a rising number of patients suffering from heart diseases, and increasing demand for better treatment is expected to fuel the growth of the market over the corresponding period. On the other hand, the high cost of the treatment and devices may slow the growth of the market.
The Americas dominate the global market owing to a huge population suffering from pericardium diseases, strong government support for research & development, and high health care spending.
According to the Centers for Disease Control and Prevention (2014), over 610,000 people die due to heart disease in the U.S. every year. The increasing prevalence of the disease has boosted the market growth in America. Additionally, changing lifestyle and increasing smoking addiction further fuelling the growth of the market.
Europe is the second leading global market, which is followed by Asia Pacific. Asia Pacific is the fastest-growing market. Its growth is majorly driven by India, China, and Japan owing to a huge number of patients and rapidly growing economy. Governments in Asia Pacific region are supporting manufacturers for research & development, which can serve as a path for the development of the market.